Developing a model to predict accrual to cancer clinical trials: Data from an NCI designated cancer center

Praveena Iruku1, Martin Goros2, Jonathan Gelfond2

  • 1Department of Hematology/Oncology, University of Colorado Health, Colorado Springs, CO, USA.

Abstract

Insights

Predicting clinical trial accrual is crucial for cancer centers. A new model identifies factors like sponsor type and trial phase, helping improve accrual rates and resource allocation.

Area of Science:

  • Oncology
  • Clinical Trial Management
  • Biostatistics

Background:

  • Cancer center funding necessitates efficient resource allocation, particularly for clinical trial infrastructure.
  • A significant percentage of clinical trials (20%) fail to meet patient accrual targets, impacting research progress.
  • Identifying factors influencing clinical trial accrual is essential for optimizing institutional performance.

Purpose of the Study:

  • To identify key factors associated with clinical trial patient accrual.
  • To develop a predictive model for clinical trial accrual at a cancer center.

Main Methods:

  • A retrospective analysis of 297 clinical trials conducted between 1999 and 2015 at UT Health Cancer Center San Antonio.
  • Inclusion of both observational and interventional studies, collecting data on study type, malignancy, trial phase, and principal investigator (PI).

Main Results:

  • Several factors significantly correlated with clinical trial accrual, including sponsor type, trial phase, disease category, study type, disease state, and the use of new investigational agents.
  • A predictive model achieved an Area Under the Curve (AUC) of 0.65.
  • Observational, interventional, industry-sponsored trials, and those led by local PIs demonstrated higher likelihoods of meeting accrual goals.

Conclusions:

  • Key factors influencing clinical trial accrual were successfully identified.
  • A predictive model for clinical trial accrual was developed based on these identified factors.
  • The model holds potential to enhance the cancer center's clinical trial portfolio and inform strategic fund allocation.

Related Concept Videos

Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
1.4K
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.2K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.6K
Design Example: Setting a Curve Using Design Data01:09

Design Example: Setting a Curve Using Design Data

Designing and plotting a curve using field data requires precise calculations and execution. A horizontal curve with a radius of 200 meters and an intersection angle of 20 degrees is established using the method of perpendicular offsets from the long chord. The long chord, which spans between the curve's endpoints, is calculated to be 69.46 meters in length. To maintain accuracy in plotting, intervals of 3 meters are selected along the chord.The engineer determines the offset distances for each...
231
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.4K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
53.6K